Grand River Aseptic Manufacturing (GRAM), a provider of parenteral solutions, is now under majority ownership of Arlington Capital Partners, a private equity firm in the Washington, D.C., area. The new partnership will enable GRAM to meet the growing development and commercial demand in many sectors of the injectables market, including biologics and generics.   GRAM’s facilities support pharmaceutical development, cGMP manufacturing, analytical testing, and regulatory filing. They were r...